Innovative Global Network for Infectious disease Theranostics & Excellence (IGNITE@GIST InnoCORE)
KEYWORDKeyword
OBJECTIVE Objectives
To develop three transformative platforms (NGuRAST / U-SFD /ACE-lysin) addressing ≧7 of WHO’s top-10 unmet infectious disease challenges;
train 50+ next-generation leaders; and generate ≥6 technology transfers, ≥25 patents, and ≥80 SCI publications over 5 years.
INTRODUCTION Director's Message
Dear colleagues and partners,
I am Prof. Sung Yang, Director of IGNITE@GIST InnoCORE.
Our center unites 16 PIs across Korea’s leading research universities and 13 world-class Global Mentors from UCLA, Harvard Medical School, Caltech, Rockefeller University, and Max Planck Institute
We are committed to delivering a Sample-to-Treatment platform that eliminates the critical barriers in infectious disease response — breaking the walls of time (sepsis rapid diagnostics), resistance (AMR therapeutics), and transmission (saliva-based multiplex POC).
Join us in redefining the global standard for infectious disease theranostics.
IMPACT Impact
▶ Talent
Train 50+ infectious disease specialists → restore K-biosecurity pipeline & establish national tech sovereignty
▶ Industry
≥6 technology transfers, 1 spinoff, new K-diagnostics/biotech market ecosystem
▶ Healthcare
Secure Golden Hour in sepsis management, suppress AMR spread, reduce medical costs by 30%
▶ Global
Supply Korean-origin IP to the CAGR 5.7% growing IVD market; lead global biodefense technology standards
TALENT Ideal Talent
1) Challenger spirit for high-risk, high-return original research
(2) Convergence expertise across BioMEMS, AI, nanomedicine, and clinical translation
(3) Global leadership through active co-research with world-class mentors
(4) Social impact orientation toward tech sovereignty and human health
(5) Entrepreneurial mindset targeting technology transfer and spinoff creation.